Synthesis and Characterization of Ruthenacarborane Complexes Incorporating Chelating N-Donor Ligands: Unexpected Luminescence from the Complex [3-CO-3,3-{κ2-Me2N(CH2)2NMe2}-closo-3,1,2-RuC2B9H11]

The Rise of Boron-Containing Compounds: Advancements in Synthesis, Medicinal Chemistry, and Emerging Pharmacology

Boron-containing compounds (BCC) have emerged as important pharmacophores. To date, five BCC drugs (including boronic acids and boroles) have been approved by the FDA for the treatment of cancer, infections, and atopic dermatitis, while some natural BCC are included in dietary supplements. Boron's Lewis acidity facilitates a mechanism of action via formation of reversible covalent bonds within the active site of target proteins. Boron has also been employed in the development of fluorophores, such as BODIPY for imaging, and in carboranes that are potential neutron capture therapy agents as well as novel agents in diagnostics and therapy. The utility of natural and synthetic BCC has become multifaceted, and the breadth of their applications continues to expand. This review covers the many uses and targets of boron in medicinal chemistry.

Synchrotron-Based Fourier-Transform Infrared Micro-Spectroscopy (SR-FTIRM) Fingerprint of the Small Anionic Molecule Cobaltabis(dicarbollide) Uptake in Glioma Stem Cells

The anionic cobaltabis (dicarbollide) [3,3'-Co(1,2-C2B9H11)2]-, [o-COSAN]-, is the most studied icosahedral metallacarborane. The sodium salts of [o-COSAN]- could be an ideal candidate for the anti-cancer treatment Boron Neutron Capture Therapy (BNCT) as it possesses the ability to readily cross biological membranes thereby producing cell cycle arrest in cancer cells. BNCT is a cancer therapy based on the potential of 10B atoms to produce α particles that cross tissues in which the 10B is accumulated without damaging the surrounding healthy tissues, after being irradiated with low energy thermal neutrons. Since Na[o-COSAN] displays a strong and characteristic ν(B-H) frequency in the infrared range 2.600-2.500 cm-1, we studied the uptake of Na[o-COSAN] followed by its interaction with biomolecules and its cellular biodistribution in two different glioma initiating cells (GICs), mesenchymal and proneural respectively, by using Synchrotron Radiation-Fourier Transform Infrared (FTIR) micro-spectroscopy (SR-FTIRM) facilities at the MIRAS Beamline of ALBA synchrotron light source. The spectroscopic data analysis from the bands in the regions of DNA, proteins, and lipids permitted to suggest that after its cellular uptake, Na[o-COSAN] strongly interacts with DNA strings, modifies proteins secondary structure and also leads to lipid saturation. The mapping suggests the nuclear localization of [o-COSAN]-, which according to reported Monte Carlo simulations may result in a more efficient cell-killing effect compared to that in a uniform distribution within the entire cell. In conclusion, we show pieces of evidence that at low doses, [o-COSAN]- translocates GIC cells' membranes and it alters the physiology of the cells, suggesting that Na[o-COSAN] is a promising agent to BNCT for glioblastoma cells.

Ruthenacarborane-Phenanthroline Derivatives as Potential Metallodrugs

Ruthenium-based complexes have received much interest as potential metallodrugs. In this work, four Ru^II complexes bearing a dicarbollide moiety, a carbonyl ligand, and a phenanthroline-based ligand were synthesized and characterized, including single crystal diffraction analysis of compounds 2, 4, and 5 and an observed side product SP1. Complexes 2-5 are air and moisture stable under ambient conditions. They show excellent solubility in organic solvents, but low solubility in water.

Ruthenium carboranyl complexes with 2,2′-bipyridine derivatives for potential bimodal therapy application

The substituents at the bipyridine lead to different cell uptake and stability.

Spectroscopic and Electronic Properties of Molybdacarborane Complexes with Non-innocently Acting Ligands

The molybdacarboranes [3-{L-κ² N,N}-3-(CO)₂ -closo-3,1,2-MoC₂ B₉ H₁₁ ] (L=2,2'-bipyridine (2,2'-bpy, 1 a) or 1,10-phenanthroline (1,10-phen, 1 b)) incorporating well-known potentially non-innocent ligands (CO, 2,2'-bpy, 1,10-phen) and the "non-spectator" nido-carborane ([η⁵ -C₂ B₉ H₁₁ ]^2- ) ligand were prepared and fully characterised. High-resolution mass spectrometry, single-crystal X-ray diffraction methods, spectroscopy (IR, (resonance) Raman, NMR), cyclic voltammetry and spectroelectrochemistry (electrochemical properties) were supported by theoretical investigations of the electronic structure (DFT, CAS-SCF, TD-DFT).

Luminescent Metal Complexes Featuring Photophysically Innocent Boron Cluster Ligands

We report the synthesis and characterization of a series of d8 metal complexes featuring robust and photophysically innocent strong-field chelating 1,1'-bis(o-carborane) (bc) ligand frameworks. A combination of UV-Vis spectroscopy, single crystal X-ray structural analysis, and DFT calculations of these species suggest that the dianionic bc ligand does not contribute to any visible metal-to-ligand charge transfer (MLCT) transitions, yet it provides a strong ligand field in these complexes. Furthermore, a bc-based Pt(II) complex containing a 4,4'-di-tert-butyl-2,2'-bipyridine ligand (dtb-bpy) has been prepared and was found to display blue phosphorescent emission dominated by MLCT from the Pt(II) center to the dtb-bpy ligand. Importantly, the bulky three-dimensional nature of the bc ligand precludes intermolecular Pt(II)⋯Pt(II) interactions in the solid state where the resulting compounds retain their emission properties. This study opens a potentially new avenue for designing organic light-emitting diode (OLED) materials with tunable properties featuring photophysically innocent boron-rich cluster ligands.

Synthesis, Characterization, and UV−vis Linear Absorption of Centrosymmetric π-Systems Incorporating closo-Dodecaborate Clusters

Single- and multibranched centrosymmetric derivatives incorporating B12 clusters [B12H11-N(H)=C(H)-C6H4-C6H4-C(H)=(H)N-B12H11]2- (3) and [1,3,5-(4-(B12H11-N(H)=C(H))-C6H4)-C6H3]3- (5) have been synthesized. Both derivatives were characterized by multinuclear NMR and ESI-MS analyses. To the best of our knowledge, compound 5 is the first example of a multicage derivative bearing three B12 units. Compounds 3 and 5 are only slightly yellowish colored. The UV-vis absorption curves of 3 and 5 show intense absorption bands at 360 and 314 nm, respectively. This result permits us to confirm the strong donor effect of the B12 cluster. The hypsochrome effect observed for compound 5 compared to that of compound 3 confirms the interest in multibranched derivatives for the preparation of two-photon absorption materials active in the visible range.

Dual fluorescence from an isonido ReIII rhenacarborane phosphine complex, [7,10-mu-H-7-CO-7,7-(PPh3)2-isonido-7,8,9-ReC2B7H9]

The complex [7,10-mu-H-7-CO-7,7-(PPh3)2-isonido-7,8,9-ReC2B7H9] has been synthesized by treatment of the complex salt [NHMe3][3,3-Cl2-3,3-(CO)2-closo-3,1,2-ReC2B9H11] with PPh3 in refluxing THF (tetrahydrofuran) and isolated as intensely colored orange-red microcrystals. Spectroscopic NMR and IR data have suggested that the product has a highly asymmetric structure with two inequivalent PPh3 ligands and a single CO ligand. Measurement of 11B NMR spectra in particular have indicated seven distinct boron vertexes, although the resulting cage degradation by removal of two BH vertexes was confirmed only following X-ray crystallographic analysis, which revealed the pentadecahedral isonido-7,8,9-ReC2B7 architecture. The 11B NMR resonances span an enormous chemical shift range (Deltadelta = 113), and this appears to be a direct consequence of the deshielding of the boron vertex directly opposite the quadrilateral |ReCCB| aperture. The new complex has been shown by electrochemical measurements to undergo a reversible one-electron oxidation. Digitally simulated cyclic voltammograms support a proposed square scheme (E(1/2) = 0.58, 0.69 V vs ferrocene) involving a reversible isonido-closo transition of the metallacarborane cage. Most unusually for a metallacarborane complex, ambient temperature solutions in CH2Cl2 and DMF have been shown to be intensely turquoise-blue fluorescent (lambda(em) = 442 nm, Phi = 0.012). Fluorescence spectroscopy measurements in MeTHF (2-methyltetrahydrofuran) glass at 77 K have indicated that the likely cause of such a broad emission is dual fluorescence (lambda(em) = 404, 505 nm), with both emissions displaying vibronic structure. Following excited-state lifetime decay analysis, the emissive behavior has been accredited to metal-perturbed 1IL states, with the lower energy emission arising from a slight geometric distortion of the initially excited complex.